Unknown

Dataset Information

0

Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.


ABSTRACT:

SUBMITTER: Boesen K 

PROVIDER: S-EPMC8869321 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.

Boesen Kim K   Paludan-Müller Asger Sand AS   Gøtzsche Peter C PC   Jørgensen Karsten Juhl KJ  

The Cochrane database of systematic reviews 20220224


<h4>Background</h4>Attention deficit hyperactivity disorder (ADHD) is a psychiatric diagnosis increasingly used in adults. The recommended first-line pharmacological treatment is central nervous system (CNS) stimulants, such as methylphenidate, but uncertainty remains about its benefits and harms.<h4>Objectives</h4>To assess the beneficial and harmful effects of extended-release formulations of methylphenidate in adults diagnosed with ADHD.<h4>Search methods</h4>We searched CENTRAL, MEDLINE, Emb  ...[more]

Similar Datasets

| S-EPMC8092481 | biostudies-literature
| S-EPMC8763351 | biostudies-literature
| S-EPMC10042435 | biostudies-literature
| S-EPMC5567875 | biostudies-literature
| S-EPMC4449164 | biostudies-literature
| S-EPMC6485546 | biostudies-literature
| S-EPMC6513464 | biostudies-literature
| S-EPMC4863687 | biostudies-literature
| S-EPMC5651935 | biostudies-literature
| S-EPMC5178023 | biostudies-literature